LYRA - Balance Sheet - Lyra Therapeutics, Inc.

Current Liabilities	12.6 M
Accounts Payable	1.18 M
Short-Term Debt	4.12 M
Other Current Liabilities	7.33 M
Non-Current Liabilities	42.1 M
Long-Term Debt	0
Other Non-Current Liabilities	42.1 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018
ASSETS
Cash & Cash Equivalents	40.6	22.4	32.5	45.7	74.6	9.8	23.9
Short Term Investments	0	80.4	65.3	0	0	0	0
Receivables	0	0	0	0	0	0	0.2
Inventory	0	0	0	0	0	0	0
Other Current Assets	2.4	2.1	2.9	4.3	2.6	0.3	0.9
Total Current Assets	43.0	104.8	100.8	47.9	75.9	10.1	24.9
PP&E	21.3	35.3	4.5	5.9	4.5	3.4	0.1
Intangible Assets	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0
Long Term Investments	0	0	1.4	0.3	0.3	0.3	0.3
Other Long Term Assets	2.0	2.5	3.3	0.8	0.1	1.1	0
Other Assets	0	0	0	0	0	0	0
Total Assets	66.3	142.6	110.0	54.9	80.8	15.0	25.4
LIABILITIES
Accounts Payable	1.2	3.1	2.6	3.1	0.9	1.1	0.6
Short Term Debt	4.1	8.9	3.5	2.1	2.0	0.9	0
Other Current Liabilities	6.9	9.4	9.0	3.2	2.0	3.2	1.3
Total Current Liabilities	12.6	19.6	14.5	18.2	4.9	5.2	2.0
Long Term Debt	0	21.4	0.7	0.4	1.5	2.4	0
Deferred Tax Income	0	0	(14.1)	(1.9)	0	0	0
Other Liabilities	0	0	0	0	0	0	130.5
Total Liabilities	54.8	53.2	29.2	20.6	6.3	7.6	132.4
EQUITY
Common Stock	65 K	57 K	32 K	13 K	13 K	6 K	6 K
Retained Earnings	(404.8)	(311.4)	(248.7)	(193.4)	(149.9)	(127.8)	(111.5)
Other Accumulative Comprehensive Income/Loss	0	33 K	10 K	0	(80.8)	0	(2.8)
Total Equity	11.6	89.4	80.8	34.3	74.5	7.3	(107.1)
Total Liabilities and Equity	66.3	142.6	110.0	54.9	80.8	15.0	25.4
SHARES OUTSTANDING
Common Shares Outstanding	65.1	49.8	30.2	13.0	8.6	12.9	6.3

Free